IPG Photonics Corporation (IPGP) M&A Call Transcript

IPG Photonics Corporation (IPGP) M&A Call July 17, 2026 8:00 AM EDTCompany ParticipantsEugene Fedotoff - Senior Director of Investor RelationsMark Gitin...

Company Participants Eugene Fedotoff - Senior Director of Investor Relations Mark Gitin - CEO & Director Timothy P.V. Mammen - Senior VP & CFO Conference Call Participants Ruben Roy - Stifel, Nicolaus & Company, Incorporated, Research Division James Ricchiuti - Needham & Company, LLC, Research Division Michael Feniger - BofA Securities, Research Division Scott Graham - Seaport Research Partners Presentation Operator Good morning, and welcome to IPG Photonics' conference call to discuss the company's acquisition of Lumibird Medical. Today's call is being recorded and webcast. At this time, I would like to turn the call over to Eugene Fedotoff, IPG's Senior Director, Investor Relations, for introductions.

Please go ahead with your conference. Eugene Fedotoff Senior Director of Investor Relations Thank you, and good morning, everyone. With me today is IPG Photonics' CEO, Dr. Mark Gitin; and Senior Vice President and CFO, Tim Mammen.

Today's call will cover IPG's proposed acquisition of Lumibird Medical. Let me remind you that statements made during this call that discuss our expectations or predictions of the future are forward-looking statements. These forward-looking statements are subject to risks and uncertainties that could cause the company's actual results to differ materially from those projected in such forward-looking statements.

These risks and uncertainties are discussed in our Form 10-K for the period ended December 31, 2025, and our reports on file with the Securities and Exchange Commission. Any forward-looking statements made on this call are the company's expectations or predictions as of today, July 17, 2026, only, and the company assumes no obligation to publicly release any updates or revisions to any such statements. During this call, we will be referring to certain non-GAAP measures, including measures derived from or aligned with IFRS reporting standards as well as other non-GAAP measures.

Such